Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | GBA1 | P04062 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.30 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22147676 | 0.88 | SMN1; SMN2 (0.36) | SMN1; SMN2HIF1AGBA1PDK2ABCB1 | |
| SCHEMBL22147602 | 0.88 | PDK2 (0.36) | SMN1; SMN2HIF1AGBA1PDK2ABCB1 | |
| SCHEMBL22147627 | 0.86 | ALDH1A1 (0.32) | SMN1; SMN2ABCB1ABCG2 | |
| SCHEMBL22147686 | 0.85 | SMN1; SMN2 (0.34) | SMN1; SMN2HIF1AGBA1PDK2ABCB1 | |
| SCHEMBL22147495 | 0.85 | ALDH1A1 (0.33) | SMN1; SMN2HIF1AABCB1ABCG2 | |
| SCHEMBL22147694 | 0.85 | ALDH1A1 (0.33) | SMN1; SMN2HIF1AABCB1ABCG2 | |
| SCHEMBL22147586 | 0.84 | CYP1A2 (0.32) | ABCG2 | |
| SCHEMBL22147505 | 0.83 | SMN1; SMN2 (0.33) | SMN1; SMN2HIF1AABCB1ABCG2 | |
| SCHEMBL22147675 | 0.82 | SMN1; SMN2 (0.33) | SMN1; SMN2HIF1APDK2 | |
| SCHEMBL21701977 | 0.80 | PDK2 (0.36) | GBA1PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200199149-A1 | ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND | LG DISPLAY CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200199149-A1 | ORGANIC COMPOUND, ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE COMPOUND | OCIAD1, OSTC, OCIAD2 | SMN1; SMN2 3089/4885HIF1A 4437/4885GBA1 3335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.